Neuraptive Therapeutics Licenses Innovative Bioresorbable Nerve Stimulation Technology from Washington University in St. Louis

CHESTERBROOK, Pa. — Neuraptive Therapeutics, Inc., a clinical-stage biotech company focused on peripheral nerve injuries, announced today that it has secured an exclusive license from Washington University in St. Louis for a bioresorbable wireless electronic stimulation device. Developed by researchers at WashU Medicine in collaboration with Northwestern University, the technology delivers targeted electrical pulses to […]